Alteplase administration in acute ischemic stroke (AIS) has been associated with errors.
A recent study looked at the types of errors that occurred at regional hospitals and Comprehensive Stroke Centers.
19.8% (133/676) of patients had an error associated with alteplase administration with the majority occurring at regional hospitals without stroke certification.
The most common error was over-dosage of alteplase, occurring in 5% (36) of patients.
Other common errors included under-dosage, infusion errors, and apparent contraindications.
The most common contributing factor leading to the error was incorrect calculation.
Administration error was associated with higher rate of hemorrhagic conversion (12.7% vs. 7.1%, p=0.04).
Bottom Line: Alteplase administration in acute ischemic stroke is associated with errors, most commonly with over-dosage of the medication.
References
Dancsecs KA, Nestor M, Bailey A, Hess E, Metts E, Cook AM. Identifying errors and safety considerations in patients undergoing thrombolysis for acute ischemic stroke. Am J Emerg Med. 2021;47:90-94.
